As of 2025-03-17, the Relative Valuation of Moderna Inc (MRNA) is (125.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.62 USD, the upside of Moderna Inc based on Relative Valuation is -463.2%.
The range of the Relative Valuation is (106.14) - (142.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 16.5x | 14.0x |
| Forward P/E multiples | 11.1x - 15.4x | 13.2x |
| Fair Price | (106.14) - (142.14) | (125.75) |
| Upside | -406.6% - -510.6% | -463.2% |
| Date | P/E |
| 2025-03-14 | -3.75 |
| 2025-03-13 | -3.72 |
| 2025-03-12 | -3.79 |
| 2025-03-11 | -3.66 |
| 2025-03-10 | -3.90 |
| 2025-03-07 | -3.86 |
| 2025-03-06 | -3.72 |
| 2025-03-05 | -3.81 |
| 2025-03-04 | -3.29 |
| 2025-03-03 | -3.28 |
| 2025-02-28 | -3.35 |
| 2025-02-27 | -3.37 |
| 2025-02-26 | -3.64 |
| 2025-02-25 | -3.61 |
| 2025-02-24 | -3.67 |
| 2025-02-21 | -3.85 |
| 2025-02-20 | -3.65 |
| 2025-02-19 | -3.89 |
| 2025-02-18 | -3.87 |
| 2025-02-14 | -3.57 |
| 2025-02-13 | -3.46 |
| 2025-02-12 | -3.31 |
| 2025-02-11 | -3.35 |
| 2025-02-10 | -3.45 |
| 2025-02-07 | -3.53 |
| 2025-02-06 | -3.64 |
| 2025-02-05 | -3.79 |
| 2025-02-04 | -3.70 |
| 2025-02-03 | -3.96 |
| 2025-01-31 | -4.27 |
| 2025-01-30 | -4.45 |
| 2025-01-29 | -4.41 |
| 2025-01-28 | -4.87 |
| 2025-01-27 | -4.51 |
| 2025-01-24 | -4.49 |
| 2025-01-23 | -4.59 |
| 2025-01-22 | -4.17 |
| 2025-01-21 | -3.89 |
| 2025-01-17 | -3.69 |
| 2025-01-16 | -3.66 |
| 2025-01-15 | -3.77 |
| 2025-01-14 | -3.73 |
| 2025-01-13 | -3.81 |
| 2025-01-10 | -4.58 |
| 2025-01-08 | -4.68 |
| 2025-01-07 | -5.15 |
| 2025-01-06 | -4.61 |
| 2025-01-03 | -4.57 |
| 2025-01-02 | -4.55 |
| 2024-12-31 | -4.51 |